TCRT — Alaunos Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Alaunos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	115	76.1	39.1	6.06	1.09
Net Total Accounts Receivable
Net Total Receivables	4.67	1.11	0.004	0.001	0.005
Prepaid Expenses
Total Other Current Assets
Total Current Assets	131	78.8	53.8	8.26	2.75
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	14.9	15.4	10.6	0.002	0
Other Long Term Assets
Total Assets	146	94.9	64.9	8.26	2.75
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	18.4	16	24.2	1.96	0.692
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.4	36.8	26.4	1.96	0.692
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	124	58.1	38.6	6.31	2.06
Total Liabilities & Shareholders' Equity	146	94.9	64.9	8.26	2.75
Total Common Shares Outstanding